<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="joint and muscle pain in humans. Though the fever and" exact="rash" post="resolve, joint and muscle pain can be long lasting."/>
 <result pre="Two preclinical vaccines, the live-attenuated CHIKV/IRES vaccine and the modified" exact="vaccinia virus" post="Ankara (MVA) vectored vaccine, assessed the impact of vaccine-induced"/>
 <result pre="not protect A129 mice from CHIKV (18). However, a modified" exact="vaccinia virus" post="ankara (MVA) vaccine vector that expresses E3/E2 was shown"/>
 <result pre="of C57BL/6 mice with CHIKV results in edema, arthritis, and" exact="tenosynovitis" post="in the ankle joint, as well as necrosis in"/>
 <result pre="cells may protect against Venezuelan Equine Encephalitis virus (VEEV) -induced" exact="encephalitis" post="in mice (28). In the current study, we utilized"/>
 <result pre="patients who recovered from CHIKV and patients with chronic CHIKV-induced" exact="arthritis" post="both had roughly equal frequencies of CHIKV-specific IFNγ-producing T"/>
 <result pre="(2013) 7:e2137. 10.1371/journal.pntd.000213723556021 4.CouturierEGuilleminFMuraMLéonLVirionJMLetortMJet al.. Impaired quality of life after" exact="chikungunya" post="virus infection: a 2-year follow-up study. Rheumatology. (2012) 51:1315–22."/>
 <result pre="follow-up study. Rheumatology. (2012) 51:1315–22. 10.1093/rheumatology/kes01522427407 5.PowersAMLogueCH. Changing patterns of" exact="chikungunya" post="virus: re-emergence of a zoonotic arbovirus. J Gen Virol."/>
 <result pre="arbovirus. J Gen Virol. (2007) 88:2363–77. 10.1099/vir.0.82858-017698645 6.WeaverSC. Arrival of" exact="chikungunya" post="virus in the new world: prospects for spread and"/>
 <result pre="of a recombinant human monoclonal antibody reduces the severity of" exact="chikungunya" post="virus disease in rhesus macaques. PLoS Negl Trop Dis."/>
 <result pre="Dis. (2017) 11:e0005637. 10.1371/journal.pntd.000563728628616 12.ChangLJDowdKAMendozaFHSaundersJGSitarSPlummerSHet al.. Safety and tolerability of" exact="chikungunya" post="virus-like particle vaccine in healthy adults: a phase 1"/>
 <result pre="Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against" exact="chikungunya" post="virus. Viruses. (2019) 11:E322. 10.3390/v1104032230987160 15.ReisingerECTschismarovRBeublerEWiedermannUFirbasCLoebermannMet al.. Immunogenicity, safety,"/>
 <result pre="10.3390/v1104032230987160 15.ReisingerECTschismarovRBeublerEWiedermannUFirbasCLoebermannMet al.. Immunogenicity, safety, and tolerability of the measles-vectored" exact="chikungunya" post="virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled"/>
 <result pre="PLoS Negl Trop Dis. (2019) 13:e0006919. 10.1371/journal.pntd.000691930653504 17.PlanteKWangEPartidosCDWegerJGorchakovRTsetsarkinKet al.. Novel" exact="chikungunya" post="vaccine candidate with an IRES-based attenuation and host range"/>
 <result pre="Dis. (2014) 8:e2970. 10.1371/journal.pntd.000297025058320 21.MorrisonTEOkoLMontgomerySAWhitmoreACLotsteinARGunnBMet al.. A mouse model of" exact="chikungunya" post="virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis,"/>
 <result pre="J Immunol. (2013) 190:259–69. 10.4049/jimmunol.120217723209328 23.TeoTHChanYHLeeWWLumFMAmrunSNHerZet al.. Fingolimod treatment abrogates" exact="chikungunya" post="virus-induced arthralgia. Sci Transl Med. (2017) 9:eaal1333. 10.1126/scitranslmed.aal133328148838 24.MinerJJCookLEHongJPSmithAMRichnerJMShimakRMet"/>
 <result pre="al.. Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls" exact="chikungunya" post="virus arthritis. Sci Transl Med. (2017) 9:eaah3438. 10.1126/scitranslmed.aah343828148840 25.PooYSRuddPAGardnerJWilsonJALarcherTColleMAet"/>
 <result pre="Multiple immune factors are involved in controlling acute and chronic" exact="chikungunya" post="virus infection. PLoS Negl Trop Dis. (2014) 8:e3354. 10.1371/journal.pntd.000335425474568"/>
 <result pre="28.YunNEPengBHBertkeASBorisevichVSmithJKSmithJNet al.. CD4+ T cells provide protection against acute lethal" exact="encephalitis" post="caused by Venezuelan equine encephalitis virus. Vaccine. (2009) 27:4064–73."/>
 <result pre="provide protection against acute lethal encephalitis caused by Venezuelan equine" exact="encephalitis" post="virus. Vaccine. (2009) 27:4064–73. 10.1016/j.vaccine.2009.04.01519446933 29.MatthewsDACummingsDEveleghCGrahamFLPrevecL. Development and use"/>
 <result pre="for the rescue of recombinant adenoviruses expressing high levels of" exact="rabies" post="virus glycoprotein. J Gen Virol. (1999) 80:345–53. 10.1099/0022-1317-80-2-34510073694 30.MesserleMCrnkovicIHammerschmidtWZieglerHKoszinowskiUH."/>
 <result pre="RRV Ross River virus SINV Sindbis virus VEEV Venezquelan equine" exact="encephalitis" post="virus MCMV mouse cytomegalovirus AdV Adenovirus 5 ELISA enzyme-linked"/>
</results>
